Milton, MA, United States of America

John G Seidman


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of John G Seidman

Introduction

John G Seidman is a notable inventor based in Milton, MA, who has made significant contributions to the field of medical diagnostics. With a total of two patents to his name, his work focuses on advancing the understanding and detection of genetic conditions, particularly those related to cardiomyopathy.

Latest Patents

Seidman's latest patents include a method for detecting hypertrophic cardiomyopathy-associated mutations. This innovative method provides a diagnostic tool that is crucial for identifying individuals with familial or sporadic hypertrophic cardiomyopathy. It is especially beneficial for asymptomatic individuals who may be at risk due to family history. By allowing for early diagnosis, this method enables individuals to take preventive measures, such as avoiding rigorous exercise, which can prolong their lives. Another significant patent involves methods for detecting human gamma and delta T cell receptors. This invention offers purified polypeptides that are essential for understanding T cell functions and their role in the immune response.

Career Highlights

Throughout his career, John G Seidman has worked with prestigious institutions, including Harvard College and The Brigham and Women's Hospital, Inc. His research has contributed to the advancement of genetic testing and the understanding of various diseases.

Collaborations

Seidman has collaborated with esteemed colleagues, including Christine E Seidman and Hugh Watkins, further enhancing the impact of his research in the medical community.

Conclusion

John G Seidman's contributions to medical diagnostics through his innovative patents have significantly advanced the field of genetics and disease detection. His work continues to influence the way genetic conditions are diagnosed and managed, ultimately improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…